Low-density lipoprotein receptor-deficient mice are protected against lethal endotoxemia and severe gram-negative infections

被引:189
作者
Netea, MG
Demacker, PNM
Kullberg, BJ
Boerman, OC
Verschueren, I
Stalenhoef, AFH
vanderMeer, JWM
机构
[1] UNIV NIJMEGEN HOSP,DEPT MED 541,DIV GEN INTERNAL MED,6500 HB NIJMEGEN,NETHERLANDS
[2] UNIV NIJMEGEN HOSP,DEPT NUCL MED,6500 HB NIJMEGEN,NETHERLANDS
关键词
lipopolysaccharide; gram-negative infection; tumor necrosis factor; interleukin-1; low-density lipoproteins;
D O I
10.1172/JCI118556
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Lipoproteins can bind lipopolysaccharide (LPS) and decrease the LPS-stimulated production of pro-inflammatory cytokines. We investigated the effect of increased plasma concentrations of low-density-lipoproteins (LDL) on survival and cytokine production after a lethal challenge with either LPS or live Gram-negative bacteria in LDL receptor deficient mice (LDLR-/-). The LDLR-/- mice challenged with LPS had an eightfold increased LD(50) when compared with the wild type controls (C57BI/6J), while tumor necrosis factor alpha (TNF alpha) and interleukin-l alpha (IL-1 alpha) plasma concentrations were decreased twofold. LDLR-/- mice had significantly lower and delayed mortality than control mice after infection with Klebsiella pneumoniae. No differences in the outgrowth of bacteria in the organs were present between the two groups, while circulating cytokine concentrations were decreased twofold in LDLR-/- mice. In contrast, the LPS-stimulated in vitro production of cytokines by peritoneal macrophages of LDLR-/- mice was significantly increased compared with controls. This increase was associated with enhanced specific binding of LPS to the macrophages of LDLR-/- mice. In conclusion, endogenous LDL can protect against the lethal effects of endotoxin and Gram-negative infection. At least part of this protection is achieved through decreased in vivo production of pro-inflammatory cytokines, in spite of increased cytokine production capacity.
引用
收藏
页码:1366 / 1372
页数:7
相关论文
共 36 条
[1]   PROTECTION AGAINST ENDOTOXIC-SHOCK BY A TUMOR-NECROSIS-FACTOR RECEPTOR IMMUNOADHESIN [J].
ASHKENAZI, A ;
MARSTERS, SA ;
CAPON, DJ ;
CHAMOW, SM ;
FIGARI, IS ;
PENNICA, D ;
GOEDDEL, DV ;
PALLADINO, MA ;
SMITH, DH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (23) :10535-10539
[2]  
BASIL V, 1991, J IMMUNOL, V147, P1567
[3]   PASSIVE-IMMUNIZATION AGAINST CACHECTIN TUMOR NECROSIS FACTOR PROTECTS MICE FROM LETHAL EFFECT OF ENDOTOXIN [J].
BEUTLER, B ;
MILSARK, IW ;
CERAMI, AC .
SCIENCE, 1985, 229 (4716) :869-871
[4]   CYTOKINE RESPONSE BY MONOCYTES AND MACROPHAGES TO FREE AND LIPOPROTEIN-BOUND LIPOPOLYSACCHARIDE [J].
CAVAILLON, JM ;
FITTING, C ;
HAEFFNERCAVAILLON, N ;
KIRSCH, SJ ;
WARREN, HS .
INFECTION AND IMMUNITY, 1990, 58 (07) :2375-2382
[5]   LPS-INDUCED RELEASE OF IL-1-BETA, IL-6, IL-8, TNF-ALPHA AND SCD14 IN WHOLE-BLOOD AND PBMC FROM PERSONS WITH HIGH OR LOW-LEVELS OF HDL-LIPOPROTEIN [J].
EGGESBO, JB ;
HJERMANN, I ;
LUND, PK ;
JOO, GB ;
OVSTEBO, R ;
KIERULF, P .
CYTOKINE, 1994, 6 (05) :521-529
[6]   CHYLOMICRONS CAN INHIBIT ENDOTOXIN ACTIVITY INVITRO [J].
EICHBAUM, EB ;
HARRIS, HW ;
KANE, JP ;
RAPP, JH .
JOURNAL OF SURGICAL RESEARCH, 1991, 51 (05) :413-416
[7]   CHOLESTEROL REGULATES THE CELL-SURFACE EXPRESSION OF GLYCOPHOSPHOLIPID-ANCHORED CD14 ANTIGEN ON HUMAN MONOCYTES [J].
ESFAHANI, M ;
BIGLER, RD ;
ALFIERI, JL ;
LUNDKATZ, S ;
BAUM, JD ;
SCERBO, L .
BIOCHIMICA ET BIOPHYSICA ACTA, 1993, 1149 (02) :217-223
[8]   ROLE FOR CIRCULATING LIPOPROTEINS IN PROTECTION FROM ENDOTOXIN TOXICITY [J].
FEINGOLD, KR ;
FUNK, JL ;
MOSER, AH ;
SHIGENAGA, JK ;
RAPP, JH ;
GRUNFELD, C .
INFECTION AND IMMUNITY, 1995, 63 (05) :2041-2046
[9]   INHIBITION OF ENDOTOXIN-INDUCED ACTIVATION OF HUMAN-MONOCYTES BY HUMAN LIPOPROTEINS [J].
FLEGEL, WA ;
WOLPL, A ;
MANNEL, DN ;
NORTHOFF, H .
INFECTION AND IMMUNITY, 1989, 57 (07) :2237-2245
[10]   CHYLOMICRONS ALTER THE FATE OF ENDOTOXIN, DECREASING TUMOR-NECROSIS-FACTOR RELEASE AND PREVENTING DEATH [J].
HARRIS, HW ;
GRUNFELD, C ;
FEINGOLD, KR ;
READ, TE ;
KANE, JP ;
JONES, AL ;
EICHBAUM, EB ;
BLAND, GF ;
RAPP, JH .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (03) :1028-1034